Revlon® Welcomes Gwen Stefani as Global Brand Ambassador
Revlon announced today that Gwen Stefani, singer and international fashion icon, is joining the Revlon family as the newest Global Brand Ambassador. Gwen, a three-time Grammy Award winning singer, songwriter, fashion designer and entrepreneur, will be representing the trend-setting beauty brand in global campaigns beginning this year, featuring Revlon’s empowering Choose Love™ message. Gwen, an inspiration to many by openly choosing love in her own life, is a true style and beauty influencer - as well as a makeup – and now Revlon – lover who has over 15 million devoted social media fans and followers.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170103005356/en/
Revlon Global Brand Ambassador Gwen Stefani on the set of her upcoming campaign for the global beauty brand. (Photo: Business Wire)
“We are thrilled that Gwen Stefani will be representing Revlon as a Global Brand Ambassador,” said Revlon President & CEO Fabian Garcia. “Gwen is a modern-day icon: a Grammy-winning artist, a trendsetter, an entrepreneur and loving mother. The versatility of these accomplishments demonstrates her message of female empowerment, one that strongly resonates across generations of fans.”
Born in Fullerton, California, Gwen grew up surrounded by music from a young age. She launched her music career in 1986 with the band, No Doubt. She followed that with a multi-platinum career as a solo artist, most recently with the 2016 release of her chart topping album “This Is What the Truth Feels Like”. Gwen shared her music knowledge, performance experience and individual style as a coach on NBC’s 3-time Emmy Award-winning musical competition series “The Voice,” which she will be rejoining this February for the show’s 12th season. In addition to her successful music career, she is also widely recognized as an accomplished fashion designer and entrepreneur, having created her much-loved lifestyle fashion brands. Gwen’s love of makeup started in her early teens, and has remained strong to this day, where she is known to experiment with – and rock – the best of beauty trends.
“Ever since I was a young girl, I have used makeup as a form of self-expression,” said Gwen. “I am passionate about makeup and how it can showcase your individuality and creativity. Partnering with an iconic beauty brand such as Revlon felt like a natural fit. I am so excited to continue sharing my love of makeup as a Revlon Global Brand Ambassador.”
One of Gwen’s first roles as Global Brand Ambassador will be starring in the brand’s CHOOSE LOVE™ campaign, which will begin running on broadcast, digital and social platforms in late January 2017.
“Love has been a muse for my songwriting,” commented Gwen. “Revlon’s CHOOSE LOVE™ message is an important one, and I am very excited for the opportunity to partner with Revlon and continue spreading this message of positivity and love.”
As the newest Global Brand Ambassador for Revlon, Gwen will appear in global multimedia campaigns across all media types including digital, in-store and social media. Gwen’s first beauty visual began appearing January 2nd, with her campaigns continuing to roll out globally throughout 2017.
For additional information on Revlon and to view behind-the-scenes content from Gwen’s campaigns in the coming months, visit www.Revlon.com and follow @Revlon on Facebook, Twitter, Instagram, YouTube and RevlonSnaps on Snapchat.
Victoria Ashley, 212-527-4137
Head of Revlon Global Public Relations
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21 | Pressemelding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li
Xilam: H1 2018 Revenue: +50%18.7.2018 16:00 | Pressemelding
Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t
Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38 | Pressemelding
The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign
Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05 | Pressemelding
Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d
Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 12:00 | Pressemelding
Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste
Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 09:05 | Pressemelding
Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme